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gene which caused amino acid to change from Thr to Met at
position aa118 and researched the effects of this mutation on
blood HBsAg screening test.
Methods: HBsAg Gene, which was ampliﬁed by PCR, was cloned
and sequenced, then mutational amino acids were recovered
the wild type at aa117 or/and aa118 position. By insertion of
HBsAg Genes, expressing vectors were constructed and transient
expressions were committed in 293T cells. Suspensions of cell
culture were collected and tested by the panel which contained
ten kinds of HBsAg testing kits provided by companies.
Result: The proﬁle of results tested by Panel were similar be-
tween express suspension of mutation HBsAg gene and donation
serum and most of kits but two failed. But the proﬁle was sig-
niﬁcant difference compared with normal quality control serum.
When mutation was recovered at 117 position, the proﬁle of re-
sults did not change. But mutation was recovered at 118 position,
the proﬁle of results changed, and all kits can effetely test this
HBsAg.
Conclusion:Mutation of HBsAg at 118 position which was changed
from T to M leaded to failure tests by most of kits.
PP-100 Induction of effective anti-HBV speciﬁc T cellular
responses with dendritic cells that modiﬁed by a
recombinant adenovirus vector expressing HBsAg
and CTLA-4 ScFv
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Objectives: To investigate the mechanism and evaluate the ther-
apeutic potential of Ad-S-ScFv transduced DCs in HBV transgenic
mice.
Methods: The ScFv of CTLA-4 was ligated and the recombinant
Ad-S and Ad-S-ScFv were constructed. DCs were transfected with
rAd (Ad-S-ScFv, Ad-S, etc), and HBV-Tg mice were randomly as-
signed to receive different rAd-transduced DCs twice at 3-week
intervals. The HBV speciﬁc IFN-γ+ CD8+ T cells proportion, the
HBsAg-speciﬁc T cellular proliferation and cytotoxic activity of
splenocytes were measured. The serum HBV markers and ALT
levels, the histology and the expression of HBcAg, HBsAg in
tissue samples of liver were also assessed. The expression and
phosphorlation level for the key components of the intracellular
signal pathway of MAPK and PI3K/Akt were detected.
Results: Compared with either DC/Ad-S or DNA immunization,
DC/Ad-S-ScFv can induce much stronger type I immune responses
and HBV-speciﬁc CTLs, and more signiﬁcantly reduce the titer
of serum HBsAg and HBV DNA, and also reduced the expression
of HBcAg and HBsAg in the liver of HBV-Tg mice. The phospho-
rlation expression of Erk1,2 in the liver tissue of DC/Ad-S-ScFv
immunized mice were signiﬁcant increased, but not for the the
PI3K/Akt signal protein.
Conclusion: Ad-S-ScFv transduced DCs may be a promising candi-
date for a CTL-based vaccine for chronic HBV infection, and the
combination with other antiviral strategy could probably acquire
the complete clearance of HBV DNA.
PP-101 Pattern of hepatitis B ‘e’ antigen (HBeAg) in
hepatitis B surface antigen (HBsAg) conﬁrmed
positive cases
Rabindra Nepal*,1, Dhundi Raj Sharma2. 1National Reference
Laboratory; 2Yeti Health Science Academy
Objective: The aim of this study was to explore the pattern
of HBeAg status in HBsAg true positive cases attending National
Reference Laboratory of Nepal.
Materials and Methods: Secondary data were collected by record
review. Serum specimens conﬁrmed for HBsAg positive cases
(n=512), by neutralization method using bioKit, Spain, were sub-
jected to semi-automatic enzyme immunoassay (EIA) GB, Taiwan
for the detection of HBeAg during the period of November 2006
to February 2009. Qualitative results were calculated by cut-off
formula provided in the kit insert and the produced data were
analyzed.
Results: Of the true HBsAg positive (n=512) cases, 76.17% (n=390)
were males and 23.83% (n=122) were females. Data showed that
29.49% (n=151) cases were found to be positive for HBeAg,
among which 31.28% (n=122) were males and 23.77% (n=29) were
females. Age wise distribution of HBeAg seropositivity showed
71.52% (n=108) cases were in the age group 21–50 years, the
most active and productive age group in Nepal.
Conclusion: Such higher prevalence of hepatitis B virus infection
in its actively multiplying phase poses a problem of greater
transmission rate in the communities. As males are more mobile
than females in Nepal our communities are exposed to more risk
of getting hepatitis B virus infection.
Similarly, HBeAg positive mothers may give birth to babies with
HBsAg positive status who ultimately become chronic carrier of
hepatitis B virus.
PP-102 The study of the CD4+CD25+treg induced by
human plasmacytoid dendritic cells from chronic
hepatitis B in vitro
Jun Hong*. Renmin Hospital of Wuhan University
Background: This study was undertaken to investigate whether
PDCs are involved in the generation of a higher proportion of
CD4+CD25+ Treg cells in chronic HBV infection compared with
healthy people.
Methods: The amount, phenotype, and function of Treg in CD4+
T cells primed by PDC from 46 chronic HBV patients, 25 healthy
controls, and 10 individuals with a resolved HBV infection were
studied by the ways of ﬂow cytometry, RT-PCR, ELISA and prolif-
eration assay.
Results: CD4+T cells primed by PDC from chronic HBV patient
were more effective than CD4+ T cells primed by PDC from
healthy controls and resolved HBV patients in suppressing the
HBcAg-speciﬁc proliferation and the interferon production. The
IL-10 and TGF-β1 could be also detectable in the supernatants
of PDC-primed CD4+ T cells. A higher percentage of Treg, de-
ﬁned as CD4, CD25, CD45RO, and CTLA-4-positive cells, was
detected within the population of CD4+ T cells primed by PDC
from chronic HBV patients compared with healthy controls and
individuals with a resolved HBV infection. Accordingly, CD25+Treg
from PDC-primed CD4+ T cells displayed a high Fox P3 messenger
RNA level. Depleting CD4+CD25+ Treg from CD4+ T cells primed by
PDC from chronic HBV patients, healthy volunteers and resolved
HBV patients made PDC-primed CD4+ T to lose the capability in
suppressing HBV-speciﬁc T-cell.
Conclusion: PDCs from the patients with chronic HBV infection
induce the generation of a higher proportion of CD4+CD25+ Treg
compared with the healthy peoples.
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associated with HBV replication in human
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Background: The abnormality of many growth factor expressions
involved in the formation and development of HCC, and asscosi-
ated with the alteration of gene methylation status. However,
their molecular mechanism and expression rule remains not too
clear. In the present study, we investigated the relationship
